Mild intermittent hypoxia may improve autonomic dysfunction in persons living with spinal cord injury: a preliminary snapshot.
Alexandra E Soltesz, Fei Zhao, Jill M Wecht...
https://pubmed.ncbi.nlm.nih.gov/40766908/Actively Recruiting
Led by VA Office of Research and Development · Updated on 2026-08-14
24
Participants Needed
1
Research Sites
N/A
Total Duration
This research investigates mild intermittent hypoxia MIH as a preventative treatment for autonomic dysfunction in people with spinal cord injuries SCI, especially those with injuries above the 6th thoracic vertebrae. Autonomic dysfunction leads to serious blood pressure problems like autonomic dysreflexia and orthostatic hypotension, increasing cardiovascular risks. Sleep disordered breathing SDB is also common in this group, with limited effective treatment options. The study aims to see if MIH can improve blood pressure control and related functions in veterans with SCI. Participants will be randomly assigned to receive either MIH, involving controlled breathing of low oxygen mixtures with added carbon dioxide, or a sham treatment with normal oxygen levels while in the laboratory. Both groups will use continuous positive airway pressure CPAP therapy at home for 8 days over 2 weeks if diagnosed with sleep apnea. Tests before, immediately after, and four weeks post-treatment will assess autonomic, cardiovascular, and muscle function to evaluate MIH effects. During the study, participants will undergo monitoring of blood pressure control during specific challenges lasting 6 minutes before and one day after the intervention. Additional follow-up occurs four weeks later to assess lasting impacts. Researchers will collect data on autonomic dysreflexia and orthostatic hypotension as primary and secondary outcomes. The study may inform new ways to manage autonomic dysfunction and sleep-related breathing problems in people with SCI, improving daily function and independence.
CONDITIONS
Mild Intermittent Hypoxia: A Prophylactic for Autonomic Dysfunction in Individuals With Spinal Cord Injuries
G
Gino Panza, PhD
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
VA Office of Research and Development
Lead Sponsor
John D. Dingell VA Medical Center
Collaborating Sponsor
This table compares participation in this trial with other options available for this condition. The information is drawn from published research and the trial’s study details and is provided for educational purposes only.
| Factors | Mild Intermittent Hypoxia | Sham Procedure (Room Air) |
|---|---|---|
| What it is | A procedure delivering 12 repeated 2-minute periods of reduced oxygen breathing, with partial pressure lowered to 55-60 mmHg and mild elevation of carbon dioxide, aiming to trigger the body's adaptive responses without causing ongoing hypoxia. | A placebo procedure in which participants breathe ordinary room air in the same setup, with no purposeful drop in oxygen and no added carbon dioxide, maintaining normal blood gas levels throughout. |
| Role in the trial | Tested as a possible preventive treatment for autonomic dysfunction episodes in chronic spinal cord injury. | Serves as a control group, enabling comparison of observed effects with actual hypoxic stimulus versus no hypoxia. |
| Primary use | Being evaluated as a way to reduce occurrence and severity of autonomic dysreflexia in people with chronic, motor incomplete spinal cord injuries. | Acts as a placebo for unbiased estimation of changes in autonomic function compared to MIH. |
| How it is given or performed | Participants wear a close-fitting facemask, breathe through a specialized apparatus where oxygen is lowered for 2-minute intervals and monitored for safety. Carbon dioxide is slightly increased to stabilize breathing. The session involves alternating low-oxygen and room air every 2 minutes, for 12 cycles. | Participants use the same facemask and apparatus, but oxygen concentrations remain normal and no additional gases are added. Timing and equipment match the experimental group. |
| Evidence status | Evidence from early studies suggests mild intermittent hypoxia may improve autonomic dysfunction in people living with spinal cord injury. However, published results remain preliminary and the long-term benefit for preventing autonomic dysreflexia is not established. | No direct benefit is expected from the sham procedure, as it does not provide hypoxic stimulus. In trials, the sham group is measured for comparison only. |
| Important limitations | Uncertainties include the small body of human evidence, short follow-up in previous studies, and individual variability in response. The intervention's long-term safety profile and optimal protocol remain undefined. | The sham procedure does not reflect current real-world therapies. Any improvements or lack thereof serve only to measure placebo or protocol effects. |
Disclaimer: This comparison is created with the help of artificial intelligence(AI) and may contain errors or missing information. It is not medical advice and does not mean one option is better or safer than another. Clinical trials are still being studied, and joining a trial is your choice. Please consult your healthcare professional before making any decisions.
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
Duration - 8 days over 2 weeks
Participants receive either mild intermittent hypoxia or sham air in the laboratory and use nightly in-home continuous positive airway pressure therapy if diagnosed with sleep apnea.
Daily laboratory sessions and nightly home CPAP use
Duration - 4 weeks
Participants return to the laboratory for tests evaluating autonomic, cardiovascular, and muscle function immediately after treatment and again 4 weeks later to assess lasting effects.
Two laboratory visits post-treatment
Study Type
INTERVENTIONAL
Masking
TRIPLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Have more questions? Get in touch with our team for quick support
Alexandra E Soltesz, Fei Zhao, Jill M Wecht...
https://pubmed.ncbi.nlm.nih.gov/40766908/VA Office of Research and Development
Lead Sponsor
John D. Dingell VA Medical Center
Collaborating Sponsor